Paper I — Q5
(a) (i) Enumerate the topical antifungal drugs along with their indication and side effects. 5 marks (ii) Name antihelminitic…
Enumerate the topical antifungal drugs along with their indication and side effects. 5 marks
Name antihelminitic drugs used in treatment of neurocysticercosis and also mention their side effects. 5 marks
Enumerate the cells of lymphoreticular system. Schematically represent the process of B-cell maturation. 5 marks
Make a schematic flowchart of pathogenesis of Salmonella causing enteric fever. Mention two important categories of drug resistance in Salmonella typhi. 5 marks
What are the risk factors for lung carcinoma ? Describe the morphological features of three major histological types of lung carcinoma. 4+6=10 marks
Describe the classification of cervical intraepithelial neoplasia/squamous intraepithelial lesion. Write a note on the role of Human papilloma virus in the pathogenesis of cervical carcinoma. 5+5=10 marks
Classify poisons based on the chief symptoms. Describe the legal duties of a medical practitioner in a case of suspected poisoning. 10 marks
हिंदी में प्रश्न पढ़ें
स्थल-कवकरोधी औषधियों के नाम उनके चिकित्सार्थ संकेतों तथा अनुषंगी प्रभावों के साथ गिनाइए। 5
न्यूरोसिस्टिसर्कोसिस के उपचार में प्रयुक्त होने वाली कृमिरोधी औषधियों के नाम बताइए तथा उनके अनुषंगी प्रभावों को भी उल्लिखित कीजिए। 5
लसीका-जालीय प्रणाली की कोशिकाओं के नाम गिनाइए। B-कोशिका परिपक्वता की प्रक्रिया का आरेखीय चित्रण कीजिए। 5
आरेखीय फ्लो-चार्ट के माध्यम से साल्मोनेला के रोगजनन, जिससे आंत्र ज्वर उत्पन्न होता है, को दर्शाइए। साल्मोनेला टाइफी में औषध प्रतिरोध की दो महत्वपूर्ण श्रेणियों को उल्लिखित कीजिए। 5
फुप्फुस कार्सिनोमा के जोखिम कारक तत्व कौन-कौन से हैं ? फुप्फुस कार्सिनोमा के तीन प्रमुख उतकविज्ञान प्रकारों की आकृतिक विशिष्टताओं का वर्णन कीजिए। 4+6=10
गर्भाशयप्रिवा अंतरपकला अबृंद रचना/पड़की अंतरपकला विधति के वर्गीकरण का वर्णन कीजिए। गर्भाशयप्रिवा कार्सिनोमा के रोगजनन में मानव पैपिलोमा वायरस की भूमिका पर टिप्पणी लिखिए। 5+5=10
प्रमुख लक्षणों के आधार पर विषों को वर्गीकृत कीजिए। विषाक्तता के संदिग्ध मामले में मैडिकल प्रैक्टिशनर के वैधिक दायित्वों का वर्णन कीजिए। 10
Model answer
Drafted with AI by UPSC Answer Check against this question's marking rubric, to the expected length. UPSC does not publish answers for Mains — this is one way to score well, not an official key. How we build rubrics and answers.
(a)(i) Topical antifungals
The topical antifungals, with indications and side effects, are enumerated below:
Imidazoles — clotrimazole, miconazole, ketoconazole, econazole: indicated in dermatophytosis (tinea corporis, cruris, pedis), cutaneous candidiasis and tinea versicolor; side effects are local burning, itching, erythema and rarely contact dermatitis.
Allylamines — terbinafine, naftifine: indicated in dermatophytosis and tinea versicolor; side effects include local irritation, burning and dryness (taste disturbance occurs with oral, not topical, terbinafine). Butenafine is similar.
Polyenes — nystatin, amphotericin B: nystatin is indicated in oral and cutaneous candidiasis; amphotericin B topically for candidiasis and keratomycosis. Side effects are local irritation; systemic absorption is negligible from intact skin.
Ciclopirox olamine: indicated in tinea versicolor, dermatophytosis and cutaneous candidiasis, and as an 8% nail lacquer in onychomycosis; side effects are local irritation and burning.
Morpholines — amorolfine 5% nail lacquer: onychomycosis; side effects are periungual burning and nail discolouration. Tolnaftate: dermatophytosis (not effective in candidiasis); side effects are rare irritation. Newer azoles such as sertaconazole and luliconazole are widely used in India for dermatophytosis.
Others — Whitfield's ointment (benzoic acid plus salicylic acid) for dermatophytosis, selenium sulfide and sodium thiosulfate for tinea versicolor, and griseofulvin (oral, not topical) is excluded. Rarely, systemic absorption from large eroded areas may cause systemic toxicity.
(a)(ii) Antihelminthics in neurocysticercosis
Albendazole (15 mg/kg/day, maximum 1200 mg/day, in two divided doses for 10–14 days) is the drug of choice; praziquantel (50 mg/kg/day in three divided doses for 10–14 days) is an alternative and is added to albendazole when there are more than two viable parenchymal cysts (IDSA–ASTMH 2017 guideline). Antiparasitic drugs are avoided in cysticercal encephalitis with raised intracranial pressure. Corticosteroids are co-administered to control the inflammatory reaction to dying cysts. Side effects: headache, seizures, raised intracranial pressure, nausea, alopecia, hepatotoxicity (albendazole), and dizziness, drowsiness, abdominal pain and raised transaminases (praziquantel).
(b)(i) Cells of the lymphoreticular system
The cells are: lymphocytes (T cells, B cells, natural killer cells), plasma cells, macrophages, dendritic cells (including Langerhans cells and follicular dendritic cells), reticular cells and sinusoidal lining cells of lymphoid organs.
B-cell maturation (schematic, drawn below):
(b)(ii) Pathogenesis of enteric fever
Schematic flowchart (drawn below):
Two important categories of drug resistance in Salmonella Typhi:
- Multidrug resistance (MDR): plasmid-mediated (IncHI1) resistance to the first-line drugs chloramphenicol, ampicillin and cotrimoxazole.
- Fluoroquinolone resistance / decreased ciprofloxacin susceptibility: chromosomal point mutations in gyrA and parC (quinolone-resistance determining region), sometimes with plasmid qnr genes; now the dominant pattern in South Asia, including India. Building on these, extensively drug-resistant (XDR) typhoid (MDR plus fluoroquinolone plus third-generation cephalosporin resistance via plasmid blaCTX-M-15 ESBL), first reported from Sindh, Pakistan in 2016, leaves azithromycin and carbapenems as the options.
(c) Risk factors for lung carcinoma
Smoking is the dominant risk factor, accounting for about 90% of cases, with risk proportional to pack-years; passive smoking adds risk. Radon exposure, asbestos, arsenic, chromium, nickel, silica and polycyclic aromatic hydrocarbons are occupational carcinogens. Air pollution, including biomass fuel and chulha smoke in Indian households, is an important India-specific factor. Genetic susceptibility, EGFR and ALK alterations in never-smokers, and chronic scarring (tuberculosis, interstitial fibrosis) contribute.
Morphological features of three major histological types:
Squamous cell carcinoma: typically central, arising from main or lobar bronchi; shows keratin pearls, intercellular bridges, squamous differentiation, cavitation and local invasion; strong association with smoking.
Adenocarcinoma: typically peripheral; shows glandular or lepidic patterns, mucin production, and is the commonest type in non-smokers and women; EGFR mutations are frequent in Asian populations.
Small cell carcinoma: central, arising from neuroendocrine cells; shows small cells with scant cytoplasm, hyperchromatic nuclei, nuclear moulding, crush artefact and high mitotic rate; strongly associated with smoking and paraneoplastic syndromes.
(d) Classification of CIN/SIL
Cervical intraepithelial neoplasia is classified as CIN 1 (dysplasia confined to the lower one-third of epithelium; Bethesda: low-grade squamous intraepithelial lesion, LSIL), CIN 2 (lower two-thirds; HSIL) and CIN 3 (full thickness, including carcinoma in situ; HSIL). The Bethesda system groups CIN 1 as LSIL and CIN 2 with CIN 3 as HSIL, reflecting the biological behaviour and management.
Role of HPV in pathogenesis: high-risk HPV types 16 and 18 cause about 70% of cervical cancers. Viral E6 oncoprotein binds and degrades p53, and E7 inactivates pRb, releasing E2F and driving uncontrolled proliferation. Integration of viral DNA into the host genome, with loss of E2 repression, leads to persistent E6/E7 expression, genomic instability, accumulation of mutations and progression from LSIL to HSIL to invasive carcinoma. Co-factors include early age at first intercourse, multiple partners, multiparity, smoking, immunosuppression and long-term oral contraceptive use.
(e) Classification of poisons by chief symptoms
Corrosives — strong acids and alkalis: cause burning pain in mouth, throat and stomach, with haematemesis and stricture formation.
Irritants — metallic salts, phosphorus, arsenic: cause vomiting, diarrhoea, abdominal pain and dehydration.
Neurotics — cerebral poisons: somniferous (opium, barbiturates) causing coma with pin-point pupils, inebriants (alcohol, anaesthetics) causing excitement then coma, and deliriants (datura, cannabis) causing delirium with dilated pupils; spinal poisons (strychnine) causing tetanic convulsions with a clear mind; peripheral nerve poisons (curare, hemlock) causing paralysis. Organophosphates, commonly grouped with agricultural poisons, cause a cholinergic crisis with miosis, secretions and fasciculations.
Asphyxiants — carbon monoxide, cyanide, hydrogen sulphide: cause cyanosis, hypoxia and respiratory failure.
Cardiac poisons — aconite, digitalis, oleander: cause arrhythmias, bradycardia and cardiac arrest.
Miscellaneous — drugs, food poisons, snake and scorpion venom, and pesticides.
Legal duties of a medical practitioner in suspected poisoning, under Indian law: treat first, since emergency care cannot be withheld for police formalities (Parmanand Katara v Union of India, 1989); register it as a medico-legal case and inform the police immediately (Section 39 CrPC, now Section 33 BNSS). A government doctor is bound to inform, and omission can attract Section 176/202 IPC (now Sections 211/239 BNS); a private practitioner is expected to inform in the interest of the patient and justice. The doctor must also preserve the stomach wash, vomitus, urine and blood for chemical analysis, maintain detailed and legible records of history, treatment and findings, arrange a dying declaration by a magistrate if the patient's condition is critical (recording it himself, before witnesses, only if there is no time), and attend court as a witness when summoned. The doctor must not refuse treatment, must report suspected homicide or suicide, and must be aware of Section 304B IPC/Section 80 BNS (dowry death) Section 302 IPC/Section 103 BNS where poisoning is suspected to be homicidal, and Section 328 IPC/Section 123 BNS (causing hurt by means of poison). In a death, the body is not to be released without a police inquest (Section 194 BNSS) and post-mortem, and the viscera are preserved for the forensic science laboratory.
How this answer will be evaluated
Framework: Clinical Sequence (Definition > Aetiology/Pathophysiology > Features > Investigation/Management)
What earns full marks: Comprehensive, accurate, and well-structured answers with all required elements and specific examples.
Evaluation rubric
Each sub-part is marked on its own, against the marks and word limit printed on the paper.
- (a)(i) List topical antifungal drugs with their specific indications and side effects. 5 marks
enumerate— list the items in order → one line each → no commentary
Must cover
- Imidazoles (clotrimazole etc.): dermatophytosis, candidiasis, tinea versicolor; local irritation
- Allylamines (terbinafine): dermatophytosis; local irritation
- Polyenes (nystatin, amphotericin B): oral/cutaneous candidiasis; negligible absorption
- Ciclopirox olamine; Whitfield's ointment, selenium sulfide; griseofulvin is oral not topical
Loses marks
- Listing systemic antifungals instead of topical
- Listing drugs without specific indications
Earns more
- Distinguish between azoles and allylamines
- Mention specific use for tinea versicolor
Extra mark
- Mention specific drug for onychomycosis (e.g., Amorolfine)
- (a)(ii) Identify antihelminthic drugs for neurocysticercosis and their side effects. 5 marks
enumerate— list the items in order → one line each → no commentary
Must cover
- Albendazole 15 mg/kg/day × 10–14 days (drug of choice); praziquantel 50 mg/kg/day × 10–14 days, added when >2 viable cysts
- Corticosteroids co-administered to control inflammation from dying cysts
- Side effects: headache, seizures, raised ICP, nausea, alopecia, hepatotoxicity (albendazole)
- Praziquantel: dizziness, drowsiness, abdominal pain, raised transaminases
Loses marks
- Listing drugs for other helminths (e.g., Mebendazole for soil-transmitted)
- Omitting side effects
Earns more
- Mention specific side effect of Praziquantel (e.g., headache)
- Mention monitoring of ICP
Extra mark
- Mention specific dosing regimen for NCC
- (b)(i) List lymphoreticular cells and schematically represent B-cell maturation. 5 marks
enumerate— list the items in order → one line each → no commentary
Must cover
- Cells: T/B/NK lymphocytes, plasma cells, macrophages, dendritic cells (Langerhans, follicular), reticular and sinusoidal lining cells
- B-cell maturation schematic (figure): stem → pro-B → pre-B (cytoplasmic μ) → immature B (sIgM) → mature naïve B
- Peripheral phase: follicle entry → antigen + T help → germinal centre (somatic hypermutation, class switching)
- Memory B cell / plasma cell output
Loses marks
- Listing cells without a diagram
- Confusing B-cell and T-cell maturation sites
Earns more
- Mention location of maturation (Bone marrow)
- Mention receptor rearrangement (V-D-J)
Extra mark
- Mention negative selection (central tolerance)
- (b)(ii) Flowchart of Salmonella pathogenesis and two categories of drug resistance. 5 marks
trace— start point → the stages in sequence → end point → what changed
Must cover
- Flowchart: ingestion → gastric acid survival → M-cell invasion → multiplication in lamina propria/mesenteric nodes
- Primary bacteraemia → seeding (gallbladder, liver, spleen, marrow) → secondary bacteraemia (fever, rose spots, splenomegaly)
- Week 3 ileal Peyer's patch ulceration — perforation/haemorrhage risk
- Resistance: MDR (plasmid; chloramphenicol, ampicillin, cotrimoxazole) and fluoroquinolone resistance (gyrA/parC); XDR adds ceftriaxone (blaCTX-M-15)
Loses marks
- Describing pathogenesis in prose instead of flowchart
- Listing only one category of resistance
Earns more
- Mention specific virulence factors (e.g., Type III secretion system)
- Mention specific resistance genes (e.g., blaTEM)
Extra mark
- Mention specific resistance pattern (e.g., MDR, XDR)
- (c) Risk factors for lung carcinoma and morphological features of three major types. 10 marks
describe— define → structure or process in order → labelled diagram → significance
Must cover
- Risk factors: smoking (~90%), passive smoking, radon, occupational carcinogens, air pollution (biomass), genetic, scarring
- Squamous cell carcinoma: central, keratin pearls, intercellular bridges, cavitation; smoking-associated
- Adenocarcinoma: peripheral, glandular/lepidic, mucin; commonest in non-smokers/women; EGFR in Asians
- Small cell carcinoma: central, neuroendocrine, scant cytoplasm, nuclear moulding, crush artefact; paraneoplastic syndromes
Loses marks
- Listing risk factors without morphological description
- Describing only two histological types
Earns more
- Mention specific histological features (e.g., keratin pearls, gland formation)
- Mention specific location (e.g., central vs peripheral)
Extra mark
- Mention specific molecular markers (e.g., EGFR, ALK)
- (d) Classification of CIN/SIL and role of HPV in cervical carcinoma pathogenesis. 10 marks
describe— define → structure or process in order → labelled diagram → significance
Must cover
- CIN 1 = lower third (LSIL); CIN 2 = two-thirds (HSIL); CIN 3 = full thickness incl. carcinoma in situ (HSIL)
- HPV 16 and 18 cause ~70% of cervical cancers
- E6 degrades p53; E7 inactivates pRb (releases E2F)
- Integration → loss of E2 repression → persistent E6/E7 → genomic instability → progression; co-factors listed
Loses marks
- Describing classification without HPV role
- Mentioning HPV without specific oncoproteins
Earns more
- Mention specific histological features of CIN grades
- Mention specific mechanism of E6/E7 action
Extra mark
- Mention specific screening methods (e.g., Pap smear, HPV DNA testing)
- (e) Classify poisons by chief symptoms and legal duties of medical practitioner. 10 marks
describe— define → structure or process in order → labelled diagram → significance
Must cover
- Classification by symptoms: corrosives, irritants, neurotics (cerebral – somniferous/inebriant/deliriant; spinal; peripheral), asphyxiants, cardiac, miscellaneous
- Legal duties: inform police (CrPC 39 / BNSS 33); preserve stomach wash, vomitus, urine, blood
- Treat first (Parmanand Katara), MLC registration, dying declaration via magistrate, documentation, court testimony
- BNS/IPC provisions (BNS 123/IPC 328 poisoning; 80/304B dowry death; 103/302 murder; omission BNS 211/239)
Loses marks
- Classifying poisons without legal duties
- Mentioning legal duties without specific evidence preservation
Earns more
- Mention specific symptoms for each class
- Mention specific legal procedure (e.g., FIR, post-mortem)
Extra mark
- Mention specific legal case law
What "Enumerate" is asking you to do
Produce the complete set of items asked for, countable and correctly named. The examiner marks against a checklist, so a missing item costs and an elaborated one gains nothing — where discussion is wanted the stem asks for it as a separate sub-part.
Structure that answers it
One line naming the basis on which the set is drawn → items numbered, each in a phrase or a single line → the discussion sub-part taken up separately, after the list is complete
Where marks are lost
Treating it as an essay. Six items named in six lines score better than three items explained at length.
Practice this exact question
Write your answer and it is marked point by point against the model answer above — what you covered, what you missed, what you got wrong.
Evaluate my answer →More from Medical Science 2025 Paper I
- Q2 (a) Using a well labelled diagram, trace the taste pathway from circumvallate papillae of…
- Q3 (a) A 36-year-old cyclist suffered pelvic injury while riding into a pothole on the road.…
- Q4 (a) (i) A 55-year-old lady visits surgery OPD with a three month old history of a painles…
- Q5 (a) (i) Enumerate the topical antifungal drugs along with their indication and side effec…
- Q6 (a) (i) Describe the approach to laboratory diagnosis of chronic myeloid leukemia – chron…
- Q7 (a) (i) Define 'drowning'. Enumerate the different modes of death in a case of drowning.…
- Q8 (a) (i) Describe the challenges of circulating Vaccine-Derived Poliovirus (VDPV). Add a n…